ACHE and non-small cell lung carcinoma: The IC50 values of these apoptosis inducers have significant improvement in the high level of ACHE (Figs. 2B–2D), which indicates that the high-expressed ACHE could reduce the effectiveness of the apoptosis drugs in NSCLC.